Postgraduate

Modules

Modules

ONC8027 : Cancer Drug Development and Innovative therapies (E-learning)

Semesters
Semester 2 Credit Value: 10
ECTS Credits: 5.0

Aims

This module looks at how new cancer medicines are developed, marketed and introduced into clinical practice. The wider context of the impact new concepts in personalized health care and new medicine technologies will be evaluated, including CAR-T and novel biological therapies

Outline Of Syllabus

Topics covered:

•       Product Development 1:-Challenges, Barriers and Benefits.
•       Product Development 2: Phase I/II/III/IV trials are they still relevant?
•       Product Development 3 New Models of clinical drug development
•       Innovation 1: Personalized Medicine and Biomarkers
•       Innovation 2: New therapies and Biosimilars
•       Innovation 3: CAR-T and cellular therapies: Part 1
•       Innovation 4: CAR-T and cellular therapies: Part 2
•       Innovation 5: Tumour Agnostic Treatments
•       Marketing and Promotion payer, provider and clinician perspective to prescribers
•       Models of Joint Working between industry and healthcare systems

Teaching Methods

Module leaders are revising this content in light of the Covid 19 restrictions.
Revised and approved detail information will be available by 17 August.

Assessment Methods

Module leaders are revising this content in light of the Covid 19 restrictions.
Revised and approved detail information will be available by 17 August.

Reading Lists

Timetable